Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5867718 | American Journal of Infection Control | 2015 | 36 Pages |
Abstract
Prior antimicrobial therapy, particularly with β-lactam, was the strongest unique risk factor for BSI caused by ESBL-producing E coli or K pneumoniae.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Teena MD, MPH, Dror MD, Paul C. MD, Indu K. MD, Zeinab MD, Mazin MD, Shatha MD, Ryan MD, Khawar MD, Jing J. PharmD, Jason M. PharmD, Keith S. MD,